App-Quantinova.ai

Chronic Troponin I Leak After Heart Transplantation: What is its Meaning?

Michelle Kittleson - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cardiac allograft vasculopathy

N/A

In-hospital and Early Post-discharge Troponin Elevations Among Patients Hospitalized for Heart Failure: Insights From the ASTRONAUT Trial

Faiez Zannad - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Aliskiren

SuPAR Predicts Cardiovascular Outcomes in Heart Failure Independently of High Sensitivity Troponin I

Yi-An Ko - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Calpain Inhibition Stabilizes Cytoskeletal Protein Expression in Chronically Ischemic Myocardium of Hypercholestrolemic Swine

Sharif A Sabe - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Dermatan sulfate

Elevation in Troponin-I is Associated With the Presence of Coronary Artery Disease and Increased Mortality in New Onset Atrial Fibrillation

Amrita Karve - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Coronary Artery Disease

N/A

Combination of High-sensitivity Troponin I and N-terminal Pro-B-type Natriuretic Peptide Predicts Future Hospital Admission for Heart Failure in High-risk Hypertensive Patients With Preserved Left Ventricular Ejection Fraction

Junnichi Ishii - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Stable coronary artery disease

N/A

Keeping Calm While Solving the Puzzle: An Uncommon Case of Hypertensive Emergency

Weeranun D Bode - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Subarachnoid hemorrhage

Phenoxybenzamine

A Third Troponin Sample is Neither Cost-Effective Nor Necessary in Patients Suspected of Acute Coronary Syndrome With First Two Negative Troponins

Sara Collins - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

The 99th Percentile of High-Sensitivity Assayed Troponin I is Associated With a High Risk of Death in Patients With Acute Chest Pain

Johannes T. Neumann - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

1-Hour Algorithm Based on High-Sensitivity Troponin I to Diagnose Type 1 Acute Myocardial Infarction

Nils A Sorensen - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Radiosurgery Induces Novel Protein Changes on the Endothelium of Arteriovenous Malformations: Potential for Therapeutic Targets

Vivienne S Lee - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arteriovenous fistula

Superoxide dismutase

The Effect of Isosorbidemononitrate on Myocardium in a Swine Model of Cardiac Arrest

Tao Wang - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Association of High-Sensitive Troponin I With Coronary Heart Disease Incidence Among Asymptomatic Older Adults: The ADVANCE Study

Malini Chandra - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

Synergistic Inhibition of Retinoblastoma1 and Meis2 Promotes Robust Proliferation of Adult Cardiomyocytes

Jamie Fritz - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Heart Failure-related Hyperphosphorylation of Ser199 on Cardiac Troponin I Causes Divergent Effects on Cardiac Function at Baseline and During Ischemia-reperfusion

Guangshuo Zhu - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

Isoproterenol

Undetectable Serum Cardiac Troponin I Does Not Preclude a Diagnosis of Giant Cell Myocarditis

Nicole Minkove - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell myocarditis

Pamicogrel

Treating Heart Failure with Preserved Ejection Fraction Through Troponin I Phospho-mimicry

Gi-Ho Kim - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with preserved ejection fraction

EGCG

Reversible Myocardial Ischemia Sufficient to Produce Transient Stunning Leads to Delayed Cardiac Troponin I Release That Reflects Focal Myocyte Apoptosis in the Absence of Pathological Infarction

Rebeccah F Young - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Propofol

A Transient Increase in Left Ventricular Load Leads to Cardiac Troponin I Release in the Absence of Myocardial Ischemia

Rebeccah F Young - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Advanced heart failure

Phenylephrine

Prognostic Value of Serial Changes of High-sensitivity Cardiac Troponin I and T Using Reference Change Values Among Hemodialysis Patients

Charles A. Herzog - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Cardiac arrest

N/A

Filters

350 Abstracts